Back
Repligen Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
52
RGEN
Repligen
Last Price:
142.11
Seasonality Move:
-3.11%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
149.16
Seasonality Move:
6.54%
Buy
52
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $136.39. The Score for RGEN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $146.59. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $146.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
RGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.62 | Sell |
Relative Strength Index (14 RSI): | 37.27 | Sell |
Chaikin Money Flow: | -550789 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (141.21 - 154.65) | Sell |
Bollinger Bands (100): | (130.37 - 163.43) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.42 | Sell |
Relative Strength Index (14 RSI): | 66.82 | Buy |
Chaikin Money Flow: | 1073571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
RGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 142.5 | Sell |
20-day SMA: | 145.47 | Sell |
50-day SMA: | 145.57 | Sell |
200-day SMA: | 164.93 | Sell |
8-day EMA: | 141.49 | Sell |
20-day EMA: | 145 | Sell |
50-day EMA: | 146.37 | Sell |
200-day EMA: | 156.75 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.89 | Buy |
20-day SMA: | 130.17 | Buy |
50-day SMA: | 132.66 | Buy |
200-day SMA: | 135.12 | Buy |
8-day EMA: | 128.84 | Buy |
20-day EMA: | 128.79 | Buy |
50-day EMA: | 131.25 | Buy |
200-day EMA: | 129.25 | Buy |
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.29 per share, and an increase next year of $0.46 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $1.52 per share, an increase this year of $1.66 per share, and an increase next year of $4.42 per share.
Repligen Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |